Homozygosity for CHEK2 p.Gly167Arg leads to a unique cancer syndrome with multiple complex chromosomal translocations in peripheral blood karyotype.

Published on Jul 1, 2020in Journal of Medical Genetics4.943
· DOI :10.1136/JMEDGENET-2018-105824
Tamar Paperna6
Estimated H-index: 6
(Rambam Health Care Campus),
Nitzan Sharon-Shwartzman1
Estimated H-index: 1
(Rambam Health Care Campus)
+ 12 AuthorsHagit Baris Feldman7
Estimated H-index: 7
Sources
Abstract
Background Chromosomal instability, as reflected by structural or copy-number changes, is a known cancer characteristic but are rarely observed in healthy tissue. Mutations in DNA repair genes disrupt the maintenance of DNA integrity and predispose to hereditary cancer syndromes. Objective To clinically characterise and genetically diagnose two reportedly unrelated patients with unique cancer syndromes, including multiorgan tumourogenesis (patient 1) and early-onset acute myeloid leukaemia (patient 2), both displaying unique peripheral blood karyotypes. Methods Genetic analysis in patient 1 included TruSight One panel and whole-exome sequencing, while patient 2 was diagnosed by FoundationOne Heme genomic analysis; Sanger sequencing was used for mutation confirmation in both patients. Karyotype analysis was performed on peripheral blood, bone marrow and other available tissues. Results Both patients were found homozygous for CHEK2 c.499G>A; p.Gly167Arg and exhibited multiple different chromosomal translocations in 30%–60% peripheral blood lymphocytes. This karyotype phenotype was not observed in other tested tissues or in an ovarian cancer patient with a different homozygous missense mutation in CHEK2 (c.1283C>T; p.Ser428Phe). Conclusions The multiple chromosomal translocations in patient lymphocytes highlight the role of CHK2 in DNA repair. We suggest that homozygosity for p.Gly167Arg increases patients9 susceptibility to non-accurate correction of DNA breaks and possibly explains their increased susceptibility to either multiple primary tumours during their lifetime or early-onset tumourigenesis.
📖 Papers frequently viewed together
2016
9 Authors (Yoji Kukita, ..., Kikuya Kato)
8 Citations
171 Citations
References20
Newest
Multiple primary tumors (MPTs) affect a substantial proportion of cancer survivors and can result from various causes, including inherited predisposition. Currently, germline genetic testing of MPT-affected individuals for variants in cancer-predisposition genes (CPGs) is mostly targeted by tumor type. We ascertained pre-assessed MPT individuals (with at least two primary tumors by age 60 years or at least three by 70 years) from genetics centers and performed whole-genome sequencing (WGS) on 46...
25 CitationsSource
#1Ulla Wartiovaara-Kautto (UH: University of Helsinki)H-Index: 9
#2Elina A. M. Hirvonen (UH: University of Helsinki)H-Index: 4
Last. Outi Kilpivaara (UH: University of Helsinki)H-Index: 32
view all 8 authors...
11 CitationsSource
#1Takeshi Terabayashi (Oita University)H-Index: 11
#2Katsuhiro Hanada (Oita University)H-Index: 25
Maintenance of genome integrity is essential for all organisms because genome information regulates cell proliferation, growth arrest, and vital metabolic processes in cells, tissues, organs, and organisms. Because genomes are constantly exposed to intrinsic and extrinsic genotoxic stress, cellular DNA repair machinery and proper DNA damage responses (DDR) have evolved to quickly eliminate genotoxic DNA lesions, thus maintaining the genome integrity suitably. In human, germline mutations in gene...
30 CitationsSource
#1Ksenija Nesic (University of Melbourne)H-Index: 3
#2Matthew Wakefield (University of Melbourne)H-Index: 40
Last. Iain A. McNeish (Imperial College London)H-Index: 57
view all 5 authors...
Genomic instability and mutations are fundamental aspects of human malignancies, leading to progressive accumulation of the hallmarks of cancer. For some time, it has been clear that key mutations may be used both as prognostic and predictive biomarkers, the best-known examples being the presence of germline BRCA1 or BRCA2 mutations, which are not only associated with improved prognosis in ovarian cancer, but are also predictive of response to poly(ADP-ribose) polymerase (PARP) inhibitors. Altho...
23 CitationsSource
#1Ahmad W. Almawi (McMaster University)H-Index: 7
#2Lindsay A. Matthews (McMaster University)H-Index: 6
Last. Alba Guarné (McMaster University)H-Index: 25
view all 3 authors...
Abstract Forkhead-associated (FHA) domains are small phosphopeptide recognition modules found in eubacterial and eukaryotic, but not archeal, genomes. Although they were originally found in forkhead-type transcription factors, they have now been identified in many other signaling proteins. FHA domains share a remarkably conserved fold despite very low sequence conservation. They only have five conserved amino acids that are important for binding to phosphorylated epitopes. Recent work from sever...
26 CitationsSource
#1Howard H. Y. Chang (SC: University of Southern California)H-Index: 10
#2Nicholas R. Pannunzio (SC: University of Southern California)H-Index: 11
Last. Michael R. Lieber (SC: University of Southern California)H-Index: 101
view all 4 authors...
In mammalian cells, DNA double-strand breaks (DSBs) are repaired predominantly by the non-homologous end joining (NHEJ) pathway, which includes subpathways that can repair different DNA-end configurations. Furthermore, the repair of some DNA-end configurations can be shunted to the auxiliary pathways of alternative end joining (a-EJ) or single-strand annealing (SSA).
616 CitationsSource
#1Jessica S. BrownH-Index: 7
#2Brent O'CarriganH-Index: 4
Last. Timothy A. Yap (ICR: Institute of Cancer Research)H-Index: 36
view all 4 authors...
J.S. Brown, B. O'Carrigan, and T.A. Yap acknowledge support from the Experimental Cancer Medicine Centre (to The Institute of Cancer Research) and the National Institute for Health Research Biomedical Research Centre (jointly to the Royal Marsden NHS Foundation Trust and The Institute of Cancer Research). Research in The Jackson laboratory is funded by Cancer Research UK (CRUK) program grant number C6/A18796. Core funding is provided by CRUK (C6946/A14492) and the Wellcome Trust (WT092096). S.P....
269 CitationsSource
#1Yoji KukitaH-Index: 12
#2Jiro OkamiH-Index: 31
Last. Kikuya KatoH-Index: 34
view all 9 authors...
: In clinical practice, there are a number of cancer patients with clear family histories, but the patients lack mutations in known familial cancer syndrome genes. Recent advances in genomic technologies have enhanced the possibility of identifying causative genes in such cases. Two siblings, an elder sister and a younger brother, were found to have multiple primary lung cancers at the age of 60. The former subsequently developed breast cancer and had a history of uterine myoma. The latter had i...
8 CitationsSource
#1Haim Ashkenazy (TAU: Tel Aviv University)H-Index: 17
#2Shiran Abadi (TAU: Tel Aviv University)H-Index: 5
Last. Nir Ben-Tal (TAU: Tel Aviv University)H-Index: 61
view all 7 authors...
The degree of evolutionary conservation of an amino acid in a protein or a nucleic acid in DNA/RNA reflects a balance between its natural tendency to mutate and the overall need to retain the structural integrity and function of the macromolecule. The ConSurf web server (http://consurf.tau.ac.il), established over 15 years ago, analyses the evolutionary pattern of the amino/nucleic acids of the macromolecule to reveal regions that are important for structure and/or function. Starting from a quer...
1,208 CitationsSource
#1Brian H. Shirts (UW: University of Washington)H-Index: 27
#2Silvia Casadei (UW: University of Washington)H-Index: 19
Last. Colin C. Pritchard (UW: University of Washington)H-Index: 51
view all 21 authors...
Screening multiple genes for inherited cancer predisposition expands opportunities for cancer prevention; however, reports of variants of uncertain significance (VUS) may limit clinical usefulness. We used an expert-driven approach, exploiting all available information, to evaluate multigene panels for inherited cancer predisposition in a clinical series that included multiple cancer types and complex family histories. For 1,462 sequential patients referred for testing by BROCA or ColoSeq multig...
55 CitationsSource
Cited By4
Newest
#1Thibaut S Matis (McGill University)
#2N Zayed (McGill University)H-Index: 1
Last. Yuval Tabach (HUJI: Hebrew University of Jerusalem)H-Index: 17
view all 0 authors...
It was hypothesized that variants in underexplored homologous recombination repair (HR) genes could explain unsolved multiple-case breast cancer (BC) families. We investigated HR deficiency (HRD)-associated mutational signatures and second hits in tumor DNA from familial BC cases. No candidates genes were associated with HRD in 38 probands previously tested negative with gene panels. We conclude it is unlikely that unknown HRD-associated genes explain a large fraction of unsolved familial BC.
Source
#1Gili Reznick Levi (Rambam Health Care Campus)H-Index: 1
#2Gal Larom (Rambam Health Care Campus)
Last. Karin Weiss (Rappaport Faculty of Medicine)H-Index: 11
view all 8 authors...
Germline pathogenic variants (PVs) in BRCA1/BRCA2 are well-established risk factors for breast cancer (BC) and/or ovarian cancer (OC). Founder PVs have been described in BRCA1/ BRCA2 in several genetic isolates. The Christian Arab population in the Middle East is a relatively isolated ethnic group, yet founder, or recurrent BRCA1/BRCA2 PVs have not been reported in this population. In this study we describe PVs detected in cancer susceptibility genes among a cohort of Christian Arabs from Israel...
Source
#1Lenka Stolarova (First Faculty of Medicine, Charles University in Prague)H-Index: 5
Germline alterations in many genes coding for proteins regulating DNA repair and DNA damage response (DDR) to DNA double-strand breaks (DDSB) have been recognized as pathogenic factors in hereditary cancer predisposition. The ATM-CHEK2-p53 axis has been documented as a backbone for DDR and hypothesized as a barrier against cancer initiation. However, although CHK2 kinase coded by the CHEK2 gene expedites the DDR signal, its function in activation of p53-dependent cell cycle arrest is dispensable...
11 CitationsSource
#1Rinat Bernstein-Molho (Sheba Medical Center)H-Index: 2
#2Inbal Barnes-Kedar (Rabin Medical Center)H-Index: 5
Last. Yael Goldberg (Rabin Medical Center)H-Index: 17
view all 21 authors...
Purpose While the spectrum of germline mutations in BRCA1/2 genes in the Israeli Jewish population has been extensively studied, there is a paucity of data pertaining to Israeli Arab high-risk cases.
4 CitationsSource